Status:
RECRUITING
Study of Oral Fluid Testing Approach
Lead Sponsor:
Boston Children's Hospital
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Cannabis Use
Cannabis Intoxication
Eligibility:
All Genders
18-30 years
Brief Summary
The purpose of this study is to identify and evaluate oral fluid testing as a biologic measure of cannabis use days that can be assessed remotely. The researchers will conduct this fully virtual study...
Eligibility Criteria
Inclusion
- Age 18 to 30 years
- Cannabis use on \>=1x/week in the past 30 days
- Ownership of a portable device that is capable of videoconference and videorecording (i.e., smartphone, tablet computer, or laptop computer)
- Ability to read and speak English
- Availability for duration of the study (2-3 weeks).
- To proceed to oral fluid testing, positive result for urinary TCH-COOH
Exclusion
- • Inability/unwillingness to provide contact information
Key Trial Info
Start Date :
October 27 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2027
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06891235
Start Date
October 27 2025
End Date
May 1 2027
Last Update
October 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Children's Hospital
Boston, Massachusetts, United States, 02115